CD274 and neoplasm: Furthermore, immune checkpoints such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death-ligand 1 (PD-L1) are becoming recognised as important markers of the tumour microenvironment's function in the course of the disease and its reaction to immunotherapy.